Not logged in, please login to view portfolio!

    Trainings
    Trainings
    Menu
    © 2021 SARMAAYA.PK

    GLAXO Share Price | GlaxoSmithKline Pakistan Limited

    GLAXO Share Price History

    GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO share price / stock price today is 136.00 PKR. Today volume traded in GLAXO is 7.6 K, price change is -0.73%, high price is 136.00 PKR, and low price is 135.00 PKR.

    Company Snapshot

    loading
    GLAXO
    2022-01-17 15:56:02    		 Current
    136.00    		 Change
    -1.00    		 Change %
    -0.73%    		 Volume
    7600
    Price to Earnings Ratio
    11.10    		 Earning per Share
    12.25    		 Book Value
    57.49    		 Price to Book
    2.57    		 Market Cap
    43.31 B
    Dividend
    6.50    		 Dividend Yield (%)
    4.40 %    		 Debt to Equity
    0.00    		 Net Profit Margin
    11.13 %    		 Gross Profit Margin
    24.18 %
    Current Ratio
    2.03    		 Beta
    0.85    		 Shares
    318.47 M    		 FreeFloat
    51.98 M    		 Free Float %
    16.32
    Equity to Asset(%)
    65.89    		 Interest
    55.12    		 Beta
    0.85    		 Upper Cap
    146.17    		 Lower Cap
    125.77
    52 Week High
    193.90    		 52 Week Low
    127.50    		 High
    136.00    		 Low
    135.00    		 Previous
    137.00
    GLAXO Performance
    Return (%) Absolute Return
    1 Week 1 Month 3 Month 6 Month 1 Year
    Return 3.756% 7.303% -6.285% -14.895% -25.215%
    Company Financials
    Company Announcements
    Date Announce Title Attachments
    2021-12-06 Corporate Briefing Session View PDF
    2021-10-29 Transmission of Quarterly Report for the Period Ended September 30, 2021 View PDF
    2021-10-25 Financial Results for the Quarter Ended September 30, 2021 View PDF
    2021-10-18 Board of Directors Meeting View PDF
    2021-09-17 CONVERSION OF PHYSICAL SHARES INTO BOOK ENTRY FORM View PDF
    2021-08-27 Transmission of Quarterly Report for the Period Ended 2021-06-30 View PDF
    2021-08-23 Financial Results for the Quarter ended June 30, 2021 View PDF
    2021-08-20 Board Meeting Reschedule View PDF
    2021-08-16 Board of Directors Meeting View PDF
    2021-06-01 Appointment of Chief Financial Officer and Executive Director View PDF
    2021-05-17 CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 View PDF
    2021-05-04 PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View PDF
    2021-04-30 Transmission of Quarterly Report for the Period Ended 2021-03-31 View PDF
    2021-04-28 Financial Results for the Quarter ended March 31, 2021 View PDF
    2021-04-27 CERTIFIED TRUE COPY OF RESOLUTION View PDF
    2021-04-27 MEETING IN PROGRESS View PDF
    2021-04-20 Board of Directors Meeting View PDF
    2021-04-06 Notice of Annual General Meeting View PDF
    2021-04-06 Notice of Annual General Meeting View PDF
    2021-04-06 Transmission of Annual Report for the Year Ended 2020-12-31 View PDF
    2021-04-05 PRIOR PUBLICATION NOTICE OF ANNUAL GENERAL MEETING View PDF
    2021-03-31 Material Information View PDF
    2021-03-10 Financial Results for the Year Ended December 31, 2020 View PDF
    2021-03-09 GLAXO | GlaxoSmithKline Pakistan Limited PDF
    2021-03-02 Board of Directors Meeting View PDF

    About Company

    GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

    Address
    35 - Dockyard Road, West Wharf,
    Website
    www.gsk.com.pk
    Key People
    Mr.Dmytro Oliinyk Chairperson
    Ms. Erum Shakir Rahim CEO
    Mr. Syed Azeem Abbas Naqvi Company Secretary

    Page description

    GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO Share Price / Stock Price is 136.00 PKR. You can also check; Share Price History, GLAXOPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

    GLAXO Share Price GLAXO Stock Price GlaxoSmithKline Pakistan Limited psx stock kse100 stock GLAXO Stock Price KSE100 ALLSHR KMI30 KMIALLSHR Share price History GLAXO Payouts Annoucements Snapshot GLAXO Address GLAXO CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages GLAXO Chairperson GLAXO Secretary GLAXO Website About GLAXO

    My Watchlist

    Not logged in, please login to view watchlist!

    Today's Market Performers KSE100

    Change
    loading
    About Us

    Sarmaaya was founded in 2017 by Laeeq Ahmad, and created in response to the non-existence of a web-based platform that could audit traders globally and at the same time; enable traders to share their knowledge with people interested in their strategies.

    Social Links

    © 2022 SARMAAYA.PK

    Important Links
    Disclaimer
    abcData (Pvt) Limited (Sarmaaya) is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.